Latest / Making it in Manufacturing
CPHI Milan 2026 Newsbeat: CinnaGen Receives Marketing Authorisation In Europe - Haleh Hamedifar
CinnaGen is the first company from its region to receive a European marketing authorisation for a biosimilar. Present in more than 40 countries, CinnaGen is now coming to Europe for the first time.
On Newsbeat, live at CPHI Milan 2026, Ruby Collier spoke to Haleh Hamedifar, Chairperson of CinnaGen, about the approval and the partners CinnaGen is looking for in Europe.
In this episode, Haleh covers:
(00:27) Why the European marketing authorisation, the first for a biosimilar from CinnaGen's region, is so meaningful for the company.
(00:58) How an integrated model and in-house development let…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.